Main Subject - Internet and Businesses Online

You have built a sizable email list. You have reasonable traffic. S

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ome of your subscribers buy from you.

But what if you could double e

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

verything you are doing? Double the traffic? Double the subscriptio

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ns? Double the email list? Double the open rate of your emails? Do

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

uble the conversion rate of your clickthroughs?

This is a tall state

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ment, but if you are already doing it you know it, and if you are not

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

, you should try it out to see: The subscribers you gain by writing

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

and submitting articles will opt in at twice the rate of the rest of

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

your traffic, will open their emails at double the rate of the rest o

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

f your traffic, and will buy twice as much from you.

What does that

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

mean to you? Is your opt in rate 25%? What if you could have 50%?

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

What is your open rate? Your conversion rate? What would your botto

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

m line look like if everything double?

Here’s how to do it:

1) Wri

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

te articles about topics that would interest buyers of your product.

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

Not visitors of your website, but buyers of your product. Note the

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

distinction.

2) Submit the articles to high traffic web sites and a

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

rticle directories.

3) Set up a separate tracking web page or track

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ing link for the traffic that comes from articles. That way you can

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

track the difference. And make sure you track the emails separately

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

and the conversion rates separately. I think you will be surprised.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/62415/mainsubjects-Email-Marketing--Why-You-Need-to-Use-Articles-in-Your-Email-List-Building-Strategy.html">Email Marketing - Why You Need to Use Articles in Your Email List Building Strategy</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/62415/mainsubjects-Email-Marketing--Why-You-Need-to-Use-Articles-in-Your-Email-List-Building-Strategy.html]Email Marketing - Why You Need to Use Articles in Your Email List Building Strategy[/url]

Pharmaceutical companies always look for exceptional sales people to represent them. A college degree, a strong work ethic, and good communication skills, both verbal and written, are some of the pre-requisites for a pharmaceutical sales representative.

Good customer service is vital for the success of any business or job that deals with the public. If the following three things are done consistently, customers will happily return to a business.

The study of microeconomics provides us with a clear explanation of how the free-rider problem creates a dilemma for producers in the private market. It impedes the consumers' valuation of a good, lowering profit, and ultimately raising production costs. As a producer in the private market one should understand from where this problem arises and thus learn to avoid it.

Tags

Links

Main Subject - Email Marketing - Why You Need to Use Articles in Your Email List Building Strategy

Related Articles: